| Télécharger | - Sera disponible ici le 10 février 2024
|
|---|
| DOI | Trouver le DOI : https://doi.org/10.1016/j.mbs.2023.108970 |
|---|
| Auteur | Rechercher : Gholami, Samaneh; Rechercher : Korosec, Chapin S.; Rechercher : Farhang-Sardroodi, Suzan; Rechercher : Dick, David W.; Rechercher : Craig, Morgan; Rechercher : Ghaemi, Mohammad Sajjad1; Rechercher : Ooi, Hsu Kiang1; Rechercher : Heffernan, Jane M. |
|---|
| Affiliation du nom | - Conseil national de recherches du Canada. Technologies numériques
|
|---|
| Format | Texte, Article |
|---|
| Sujet | protein subunit-based vaccine; SARS-CoV-2; COVID-19; adaptive immune response; Neutralizing Antibody (NAb); IgG antibody; mathematical modeling |
|---|
| Résumé | We consider a general mathematical model for protein subunit vaccine with a focus on the MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2, and use the model to study immunological outcomes in the humoral and cell-mediated arms of the immune response from vaccination. The mathematical model is fit to vaccine clinical trial data. We elucidate the role of Interferon-𝛾 and Interleukin-4 in stimulating the immune response of the host. Model results, and results from a sensitivity analysis, show that a balance between the T𝐻 1 and T𝐻 2 arms of the immune response is struck, with the T𝐻 1 response being dominant. The model predicts that two-doses of the vaccine at 28 days apart will result in approximately 85% humoral immunity loss relative to peak immunity approximately 6 months post dose 1. |
|---|
| Date de publication | 2023-02-10 |
|---|
| Maison d’édition | Elsevier |
|---|
| Dans | |
|---|
| Autre version | |
|---|
| Langue | anglais |
|---|
| Publications évaluées par des pairs | Oui |
|---|
| Exporter la notice | Exporter en format RIS |
|---|
| Signaler une correction | Signaler une correction (s'ouvre dans un nouvel onglet) |
|---|
| Identificateur de l’enregistrement | aad1c03a-8813-44bc-b6ca-f866a9e66428 |
|---|
| Enregistrement créé | 2023-03-17 |
|---|
| Enregistrement modifié | 2023-03-17 |
|---|
